Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 3
1983 8
1984 4
1985 3
1986 4
1987 9
1988 13
1989 9
1990 8
1991 10
1992 9
1993 17
1994 11
1995 14
1996 17
1997 23
1998 15
1999 28
2000 28
2001 35
2002 56
2003 61
2004 68
2005 80
2006 102
2007 129
2008 138
2009 159
2010 177
2011 199
2012 230
2013 293
2014 358
2015 391
2016 454
2017 509
2018 610
2019 621
2020 727
2021 826
2022 561
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

6,294 results
Results by year
Filters applied: . Clear all
Page 1
Microglia-mediated degradation of perineuronal nets promotes pain.
Tansley S, Gu N, Guzmán AU, Cai W, Wong C, Lister KC, Muñoz-Pino E, Yousefpour N, Roome RB, Heal J, Wu N, Castonguay A, Lean G, Muir EM, Kania A, Prager-Khoutorsky M, Zhang J, Gkogkas CG, Fawcett JW, Diatchenko L, Ribeiro-da-Silva A, De Koninck Y, Mogil JS, Khoutorsky A. Tansley S, et al. Among authors: cai w. Science. 2022 Jul;377(6601):80-86. doi: 10.1126/science.abl6773. Epub 2022 May 26. Science. 2022. PMID: 35617374
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.
Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Morrow JS, Pusztai L, Rimm DL, Yin M, Yan Q. Zhang M, et al. Among authors: cai wl. Sci Transl Med. 2022 Feb 2;14(630):eabf5473. doi: 10.1126/scitranslmed.abf5473. Epub 2022 Feb 2. Sci Transl Med. 2022. PMID: 35108062 Free PMC article.
Climate and health: An evolving relationship.
Carlson CJ, Torres Codeço C, Brauer M, Evengård B, Cai W, de la Fuente J, Rautio A. Carlson CJ, et al. Among authors: cai w. Med (N Y). 2021 Apr 9;2(4):344-347. doi: 10.1016/j.medj.2021.03.007. Epub 2021 Apr 9. Med (N Y). 2021. PMID: 35590154 Free article.
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study.
Liu J, Li J, Lin W, Shao D, Depypere L, Zhang Z, Li Z, Cui F, Du Z, Zeng Y, Jiang S, He P, Gu X, Chen H, Zhang H, Lin X, Huang H, Lv W, Cai W, Liang W, Liang H, Jiang W, Wang W, Xu K, Cai W, Wu K, Lerut T, Fu J, He J. Liu J, et al. Among authors: cai w. Int J Cancer. 2022 Jul 1;151(1):128-137. doi: 10.1002/ijc.33976. Epub 2022 Mar 21. Int J Cancer. 2022. PMID: 35188268 Clinical Trial.
6,294 results